Enterprise Clinical Partnerships Beacon’s FDA-cleared EEG wearables combined with an AI-driven brain data platform and Azure-based infrastructure makes it suitable for integration with large health systems, academic medical centers, or CROs. Target opportunities include joint pilots, data-sharing agreements, and EHR/PACS integration to embed Beacon into clinical workflows and trials.

Clinical Trial Enablement With AI analytics, regulatory-grade data handling, and a track record in neurology and psychiatric research, Beacon can partner with pharma and biotech sponsors to streamline trial data capture, biomarker discovery, and regulatory submissions for brain disorders.

AI Analytics Upsell Beacon’s stack (OpenAI, TensorFlow, Tableau) supports advanced analytics, custom ML model development, and interactive dashboards. There is a sales opportunity to upsell enterprise-grade analytics services, model customization, and hosted ML endpoints for researchers and clinicians.

Strong Funding Backing A landmark Series B led by GV and other top healthcare investors signals durability and credibility. Use this to engage large healthcare tech platforms, accelerators, and ecosystem partners for co-development, licensing, or channel partnerships.

Ecosystem & Events Active conference presence (SLEEP 2026, AAN 2026) and a broad investor syndicate position Beacon to recruit clinicians/researchers as early adopters, sponsor symposia, and build partnerships with neurology and sleep medicine societies to accelerate adoption.